Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1122-12-9 | MDL No. : | MFCD00030673 |
Formula : | C4Br2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GEKJEMDSKURVLI-UHFFFAOYSA-N |
M.W : | 255.85 | Pubchem ID : | 70727 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 35.98 |
TPSA : | 43.37 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.67 cm/s |
Log Po/w (iLOGP) : | 1.08 |
Log Po/w (XLOGP3) : | 1.68 |
Log Po/w (WLOGP) : | 1.07 |
Log Po/w (MLOGP) : | 0.96 |
Log Po/w (SILICOS-IT) : | 2.0 |
Consensus Log Po/w : | 1.36 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.48 |
Solubility : | 0.838 mg/ml ; 0.00328 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.21 |
Solubility : | 1.59 mg/ml ; 0.00623 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.19 |
Solubility : | 1.67 mg/ml ; 0.00652 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | at 120℃; for 16 h; Sealed tube | Synthesis of 3,4-Dibromomaleic anhydride: A mixture of maleic anhydride (2.0 g, 20.39 mmol), aluminum chloride (40.8 mg, 0.3 mmol), and bromine (2.1 ml, 40.78 mmol), was heated at 120 °C for 16 h in sealed tube. After that, it was allowed to coolroom temperature and the reaction mixture was added to ethyl acetate. The ethylacetate solution was filtered and the filtrate was evaporated. To the resulting reddishsolid, 100 nil CHC13 was added and filtered. The filtrate was evaporated to get off-white (yellow) solid in 87percent yield. 13C NMR(CDC13) ö(ppm): 131.8, 159.0. |
83% | at 160℃; for 20 h; Sealed tube | Under an inert atmosphere, a mixture of maleic anhydride (1.50 g, 15.3 mmol), A1C13 (0.30 g, 0.21 mmol) and Br2 (1.57 mL, 30.6 mmol) was heated at 160 °C in a sealed ampule for 20 h. Upon cooling to room temperature the reaction mixture was carefully opened to air, EtOAc was added the solid filtered off and repeatedly washed with further EtOAc. The filtrate was finally concentrated in vacuo to give the title compound (1) as a yellow solid (3.25 g, 12.8 mmol, 83percent). m.p. 107-110°C; vmax (cm"1) 1769, 1706, 1590; 6C (CDC13, 125 MHz) 164.4 (s), 125.9 (s); HRMS (CI) calculated for C403Br2 [M]+ 253.82087, observed: 253.82082. |
78% | at 160℃; for 16 h; Inert atmosphere; Sealed tube | Under an inert atmosphere, a solution of maleic anhydride(1.50 g, 15.3 mmol, 1 eq), aluminium trichloride (300 mg,0.21 mmol, cat.) and bromine (4.95 g, 30.6 mmol, 2 eq) was heated at 160° C. in a sealed ampule (note—blast shield) for 16 h. Upon cooling to 21° C. the reaction mixture was stirred for a further 24 h and careffilly opened to ait EtOAc was added and the solid filtered off and repeatedly washed with thrther EtOAc. The filtrate was finally concentrated in vacuo to give the title compound was a yellow solid which was used without thrther purification (3.05 g, 11.9 mmol, 78percent yield).m.p 107-110° C.; ‘3CNMR(15OMHz, CD3OD) ö 163.33 (s),125.28 (s); IR (MeOH) 1769, 1706, 1590 cm’; HRMS (CI) calcd for C40313r2 [M]253.82087, 253.82082 observed. |
[ 32978-38-4 ]
4-Bromo-5-ethoxyfuran-2(5H)-one
Similarity: 0.73
[ 61934-55-2 ]
4-(Bromomethyl)furan-2(5H)-one
Similarity: 0.60
[ 32978-38-4 ]
4-Bromo-5-ethoxyfuran-2(5H)-one
Similarity: 0.73
[ 32978-38-4 ]
4-Bromo-5-ethoxyfuran-2(5H)-one
Similarity: 0.73
[ 61934-55-2 ]
4-(Bromomethyl)furan-2(5H)-one
Similarity: 0.60